Safety and efficacy of hydrogen peroxide topical solution, 40% (w/w), in patients with seborrheic keratoses: Results from 2 identical, randomized, double-blind, placebo-controlled, phase 3 studies (A-101-SEBK-301/302)

J Am Acad Dermatol. 2018 Nov;79(5):869-877. doi: 10.1016/j.jaad.2018.05.044. Epub 2018 Jun 1.

Abstract

Background: Approved topical treatments for seborrheic keratoses (SKs) are an unmet need.

Objective: To evaluate the safety and efficacy of 40% hydrogen peroxide topical solution (HP40) versus vehicle for the treatment of SKs (A-101-SEBK).

Methods: A total of 937 patients with 4 SKs each (≥1 lesion each on the face and on the trunk and/or an extremity) were randomized 1:1 to HP40 or vehicle. At each visit, SKs were graded using the Physician's Lesion Assessment (PLA) scale (0, clear; 1, nearly clear; 2, ≤1 mm thick; and 3, >1 mm thick). After 1 treatment, SKs with a PLA score higher than 0 were re-treated 3 weeks later.

Results: At day 106, significantly more patients treated with HP40 than with vehicle achieved a PLA score of 0 on all 4 SKs (study 1, 4% vs 0%; study 2, 8% vs 0% [both P < .01]) and on 3 of 4 SKs (study 1, 13% vs 0%; study 2, 23% vs 0% [both P < .0001]). A higher mean per-patient percentage of SKs were clear (study 1, 25% vs 2%; study 2, 34% vs 1%) and clear or nearly clear (study 1, 47% vs 10%; study 2, 54% vs 5%) with HP40 than with vehicle. Local skin reactions were largely mild and resolved by day 106.

Limitations: The optimal number of treatment sessions was not evaluated.

Conclusion: Application of HP40 was well tolerated and effective in the removal of SKs.

Keywords: A-101; HP40; Physician's Lesion Assessment score; hydrogen peroxide; local skin reactions; seborrheic keratosis; topical solution.

Publication types

  • Clinical Trial, Phase III
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Administration, Topical
  • Adult
  • Aged
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Drug Administration Schedule
  • Female
  • Humans
  • Hydrogen Peroxide / therapeutic use*
  • Keratosis, Seborrheic / diagnosis*
  • Keratosis, Seborrheic / drug therapy*
  • Male
  • Middle Aged
  • Patient Safety
  • Risk Assessment
  • Treatment Outcome
  • United States

Substances

  • Hydrogen Peroxide